Last $2.08 USD
Change Today +0.23 / 12.43%
Volume 100.0
MLSS On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

milestone scientific inc (MLSS) Snapshot

Open
$2.08
Previous Close
$1.85
Day High
$2.08
Day Low
$2.08
52 Week High
05/29/14 - $2.25
52 Week Low
08/13/13 - $1.11
Market Cap
37.0M
Average Volume 10 Days
5.2K
EPS TTM
$0.08
Shares Outstanding
17.8M
EX-Date
--
P/E TM
24.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for MILESTONE SCIENTIFIC INC (MLSS)

Related News

No related news articles were found.

milestone scientific inc (MLSS) Related Businessweek News

No Related Businessweek News Found

milestone scientific inc (MLSS) Details

Milestone Scientific Inc. provides technologies and solutions for the medical and dental markets in the United States, Canada, Asia, Africa, South America, and Europe. The company’s products include STA Single Tooth Anesthesia Instrument, a computer-controlled local anesthesia delivery instrument that incorporates the pressure feedback elements of its patented CompuFlo technology, which allows dentists to administer injections into the periodontal ligament space; and CompuDent, a computer-controlled local anesthetic delivery instrument that provides painless injections for various routine dental treatments, including root canals, crowns, fillings, and cleanings. Its products also comprise CompuMed, a computer-controlled injection instrument used in various applications, such as colorectal surgery, podiatry, dermatology, cosmetic surgery, hair restoration surgery, nasal and sinus surgery, orthopedics, and others. In addition, the company provides The Wand, a hand piece that allows bi-directional rotation during injection, which prevents needle deflection that occurs with a traditional syringe. Milestone Scientific Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.

9 Employees
Last Reported Date: 03/13/14
Founded in 1989

milestone scientific inc (MLSS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $700.0K
Chief Financial Officer
Total Annual Compensation: $221.6K
Compensation as of Fiscal Year 2013.

milestone scientific inc (MLSS) Key Developments

Milestone Scientific Inc. Establishes Joint Venture Medical and Dental Distribution Company in China; Appoints Lidong Zhang as Chief Executive Officer of Milestone China

Milestone Scientific Inc. announced that it has formed a joint venture medical and dental distribution company with senior healthcare executives from China. The new joint venture, Milestone China, will be headquartered in Hong Kong and will be 40% owned by Milestone Scientific. The focus of Milestone China will be to supply and distribute medical and dental instruments, disposables and certain medications to China and other Asian markets. Milestone China will initially focus on purchasing and selling Milestone Scientific's STA Wand(R) Computer Controlled Anesthesia System and related disposables, which were recently approved by the China Food and Drug Administration. Lidong Zhang has been appointed as Chief Executive Officer of Milestone China. Prior to joining Milestone China, Mr. Zhang held senior executive positions with leading healthcare distribution companies in China, including President of China National Medicines Corporation Ltd. (CNMC), President of China National Pharmaceutical Logistics Co. Ltd, and Vice President of China National Bio-tech Group. He also served as Chairman of National Medicines Prospect Dentech (Beijing) Co. Ltd.

Milestone Scientific Inc. Appoints Gian Domenico Trombetta as Chief Executive Officer of its Dental Division

Milestone Scientific Inc. announced that it has appointed Gian Domenico Trombetta as Chief Executive Officer of its dental division. Mr. Trombetta will also serve as a member of Milestone Scientific's Board of Directors. Leonard Osser will remain Chief Executive Officer of Milestone Scientific. Mr. Trombetta is the President and CEO of Innovest S.p.A. In the past he has served as CEO and board member of numerous private commercial companies.

Milestone Scientific Inc. Announces Unaudited Financial Results for the First Quarter Ended March 31, 2014

Milestone Scientific Inc. announced unaudited financial results for the first quarter ended March 31, 2014. For the quarter, the company's revenue was $2,620,834 against $2,489,542 for the first quarter of 2013. The increase in product sales of $131,292 or 5.3% was primarily the result of increased international revenue. Net income was $194,384 or $0.01 per basic and diluted share against $150,746 or $0.01 per basic and diluted share for the comparable period in 2013. The increase in net income was attributable to an increase in sales, offset by a non-cash expense of $130,523 related to the Milestone Medical Inc. joint venture that was not incurred in 2013. Income from operations was $329,248 against $167,761 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MLSS:US $2.08 USD +0.23

MLSS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MLSS.
View Industry Companies
 

Industry Analysis

MLSS

Industry Average

Valuation MLSS Industry Range
Price/Earnings 24.6x
Price/Sales 3.6x
Price/Book 6.3x
Price/Cash Flow 24.7x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MILESTONE SCIENTIFIC INC, please visit www.milesci.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.